View Older Stories View More Recent Stories

Sep 15, 2015 05:00PM Gilead Sciences to Present at the Morgan Stanley Global Healthcare Conference on Wednesday, September 16
Sep 8, 2015 05:00PM Gilead Sciences to Present at the Baird 2015 Healthcare Conference on Wednesday, September 9
Sep 2, 2015 08:30AM Gilead’s Investigational Fixed-Dose Combination of Emtricitabine/Tenofovir Alafenamide (F/TAF) Meets Primary 48-Week Objective in Phase 3 Study
Aug 26, 2015 05:00PM Results From the AMBITION Study of First-Line Treatment With Letairis and Tadalafil in Pulmonary Arterial Hypertension Published in The New England Journal of Medicine
Aug 20, 2015 04:30PM European Medicines Agency Validates Gilead’s Marketing Application for Single Tablet Regimen Containing Rilpivirine, Emtricitabine and Tenofovir Alafenamide (R/F/TAF) for HIV Treatment
Jul 29, 2015 11:38AM Wall St higher ahead of Fed meeting
Jul 29, 2015 09:28AM Pre-Open Stock Movers 07/29: (CYT) (RUBI) (BWLD) Higher; (YELP) (DATA) (TWTR) Lower (more...)
Jul 28, 2015 06:02PM After-Hours Stock Movers 07/28: (RUBI) (BWLD) (CTXS) Higher; (YELP) (AKAM) (TWTR) Lower (more...)
Jul 28, 2015 04:02PM Gilead Sciences Announces Third Quarter 2015 Dividend
Jul 28, 2015 07:42AM Wall Street bounces back after five-day selloff
Jul 27, 2015 04:30PM Gilead Announces Executive Promotions
Jul 27, 2015 02:13PM Trading Radar for 7/28: Ford (F), Twitter (TWTR) DuPont (DD), Pfizer (PFE), UPS (UPS), US Steel (X) Report
Jul 21, 2015 05:00PM Gilead Sciences to Release Second Quarter 2015 Financial Results on Tuesday, July 28, 2015
Jul 21, 2015 02:06PM Gilead Announces Phase 3 Results From the First Study to Evaluate Switching From TDF-Based Regimens to a TAF-Based Regimen Containing Elvitegravir, Cobicistat, Emtricitabine and Tenofovir Alafenamide
Jul 3, 2015 02:00AM Japan’s Ministry of Health, Labour and Welfare Approves Gilead’s Harvoni®, the First Once-Daily Single Tablet Regimen for the Treatment of Genotype 1 Chronic Hepatitis C
Jul 1, 2015 04:30PM Gilead Submits New Drug Application to U.S. Food and Drug Administration for Single Tablet Regimen for HIV Containing Rilpivirine, Emtricitabine and Tenofovir Alafenamide (R/F/TAF)
Jun 8, 2015 05:00PM Gilead Sciences to Present at Two Upcoming Investor Conferences on Tuesday, June 9
May 31, 2015 09:00AM Zydelig® in Combination With Ofatumumab Improves Progression-Free Survival in Previously-Treated Patients With Chronic Lymphocytic Leukemia
May 28, 2015 08:30AM European Medicines Agency Validates Gilead’s Marketing Application for Fixed-Dose Combination of Emtricitabine and Tenofovir Alafenamide for HIV Treatment
May 27, 2015 05:00PM Gilead Sciences to Present at the Bernstein 31st Annual Strategic Decisions Conference on Thursday, May 28
May 18, 2015 05:00PM Gilead Sciences to Present at the UBS 2015 Global Healthcare Conference on Tuesday, May 19
May 12, 2015 05:00PM Gilead Sciences to Present at the Bank of America Merrill Lynch 2015 Health Care Conference on Wednesday, May 13
May 6, 2015 08:30AM Gilead Sciences Acquires EpiTherapeutics
Apr 30, 2015 04:02PM Gilead Sciences Declares First Quarterly Cash Dividend
Apr 25, 2015 01:00AM Gilead Announces Results From Studies Evaluating Sofosbuvir-Based Regimens in Chronic Hepatitis C Patients With Genotypes 2-5
Apr 23, 2015 05:00PM Gilead Sciences to Release First Quarter 2015 Financial Results on Thursday, April 30, 2015
Apr 23, 2015 01:00AM Gilead’s Harvoni and Sovaldi Demonstrate Efficacy and Safety among Chronic Hepatitis C Patients with Advanced Liver Disease
Apr 23, 2015 01:00AM Gilead Announces Data for Investigational, All-Oral, Pan-Genotypic Three-Drug Regimen of Sofosbuvir, GS-5816 and GS-9857 for Chronic Hepatitis C
Apr 7, 2015 05:56PM Gilead Submits New Drug Application to U.S. Food and Drug Administration for Fixed-Dose Combination of Emtricitabine/Tenofovir Alafenamide for HIV Treatment
Mar 26, 2015 02:00AM Japan’s Ministry of Health, Labour and Welfare Approves Gilead’s Sovaldi® (sofosbuvir) for the Treatment of Genotype 2 Chronic Hepatitis C
Mar 10, 2015 05:00PM Gilead Sciences to Present at the Barclays Global Healthcare Conference on Wednesday, March 11
Oct 31, 2014 12:08PM Streetinsider.com's Hot Lunchtime Reads 10/31: (LNKD) (GILD) (TWTR) (TSLA)
Oct 24, 2014 09:09AM Gilead Sciences's (GILD) Harvoni RX 445 in Week One
Oct 14, 2014 10:03AM UPDATE: Gilead Sciences (GILD) Hits Session Lows
Sep 5, 2014 09:53AM Gilead Sciences (GILD): Traders Discuss Cheaper Version of Sovaldi
May 15, 2014 10:29AM Griffin's Blue Ridge Capital Shows New Stakes in Allegion (ALLE), Castlight Health (CSLT), Myriad Genetics (MYGN), Walgreen (WAG) (more...)
Apr 15, 2014 10:41AM Stocks Choppy With Escalation of Ukraine Violence
Apr 10, 2014 01:57PM Stocks Sink; Margin Fears Take Center Stage
Apr 4, 2014 12:37PM Blood-Bath in Nasdaq Stocks
Mar 31, 2014 11:57AM Did Gilead (GILD) and Waxman Plan Meeting Ahead of Letter?
Mar 24, 2014 11:34AM Stocks Weaker, Led by High-Beta Names
Feb 14, 2014 02:07PM Blue Ridge Capital Enters Apple (AAPL), Twitter (TWTR) (more...)
Jan 8, 2014 10:38AM Notable Analyst Rating Changes 01/08: (RAD) (PNRA) (FLIR) Upgraded; (AMBA) (TWTR) (TCS) Downgraded
Dec 2, 2013 12:10PM Streetinsider.com's Hot Lunchtime Reads 12/02: (TWTR) (AMZN) (GILD) (TSLA)
View More Recent Stories View Older Stories